{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:38:50Z","timestamp":1790231930241,"version":"4.1.0"},"reference-count":42,"publisher":"American Diabetes Association","issue":"1","license":[{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"vor","delay-in-days":4000,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Hypoglycemia-associated autonomic failure (HAAF) constitutes one of the main clinical obstacles to optimum treatment of type 1 diabetes. Neurons in the ventromedial hypothalamus are thought to mediate counterregulatory responses to hypoglycemia. We have previously hypothesized that hypoglycemia-induced hypothalamic angiotensin might contribute to HAAF, suggesting that the angiotensin blocker valsartan might prevent HAAF. On the other hand, clinical studies have demonstrated that the opioid receptor blocker naloxone ameliorates HAAF. The goal of this study was to generate novel hypothalamic markers of hypoglycemia and use them to assess mechanisms mediating HAAF and its reversal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>Quantitative PCR was used to validate a novel panel of hypothalamic genes regulated by hypoglycemia. Mice were exposed to one or five episodes of insulin-induced hypoglycemia, with or without concurrent exposure to valsartan or naloxone. Corticosterone, glucagon, epinephrine, and hypothalamic gene expression were assessed after the final episode of hypoglycemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>A subset of hypothalamic genes regulated acutely by hypoglycemia failed to respond after repetitive hypoglycemia. Responsiveness of a subset of these genes was preserved by naloxone but not valsartan. Notably, hypothalamic expression of four genes, including pyruvate dehydrogenase kinase 4 and glycerol 3-phosphate dehydrogenase 1, was acutely induced by a single episode of hypoglycemia, but not after antecedent hypoglycemia; naloxone treatment prevented this failure. Similarly, carnitine palmitoyltransferase-1 was inhibited after repetitive hypoglycemia, and this inhibition was prevented by naloxone. Repetitive hypoglycemia also caused a loss of hypoglycemia-induced elevation of glucocorticoid secretion, a failure prevented by naloxone but not valsartan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Based on these observations we speculate that acute hypoglycemia induces reprogramming of hypothalamic metabolism away from glycolysis toward \u03b2-oxidation, HAAF is associated with a reversal of this reprogramming, and naloxone preserves some responses to hypoglycemia by preventing this reversal.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/db10-0326","type":"journal-article","created":{"date-parts":[[2010,9,2]],"date-time":"2010-09-02T00:01:50Z","timestamp":1283385710000},"page":"39-46","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":31,"title":["Naloxone, but Not Valsartan, Preserves Responses to Hypoglycemia After Antecedent Hypoglycemia"],"prefix":"10.2337","volume":"60","author":[{"given":"Michal M.","family":"Poplawski","sequence":"first","affiliation":[{"name":"Fishberg Center for Neurobiology, Mount Sinai School of Medicine, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason W.","family":"Mastaitis","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The Anlyan Center, Yale University School of Medicine, New Haven, Connecticut."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles V.","family":"Mobbs","sequence":"additional","affiliation":[{"name":"Fishberg Center for Neurobiology, Mount Sinai School of Medicine, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2010,9,14]]},"reference":[{"key":"2022031210074200000_B1","doi-asserted-by":"crossref","first-page":"E1115","DOI":"10.1152\/ajpendo.2001.281.6.E1115","article-title":"Hypoglycemia-associated autonomic failure in diabetes","volume":"281","author":"Cryer","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031210074200000_B2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2337\/diabetes.52.3.663","article-title":"Local lactate perfusion of the ventromedial hypothalamus suppresses hypoglycemic counterregulation","volume":"52","author":"Borg","year":"2003","journal-title":"Diabetes"},{"key":"2022031210074200000_B3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2337\/diabetes.48.3.584","article-title":"Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats","volume":"48","author":"Borg","year":"1999","journal-title":"Diabetes"},{"key":"2022031210074200000_B4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1172\/JCI119165","article-title":"Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats","volume":"99","author":"Borg","year":"1997","journal-title":"J Clin Invest"},{"key":"2022031210074200000_B5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2337\/diab.44.2.180","article-title":"Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release","volume":"44","author":"Borg","year":"1995","journal-title":"Diabetes"},{"key":"2022031210074200000_B6","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1172\/JCI117150","article-title":"Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia","volume":"93","author":"Borg","year":"1994","journal-title":"J Clin Invest"},{"key":"2022031210074200000_B7","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2337\/diabetes.54.4.952","article-title":"Acute induction of gene expression in brain and liver by insulin-induced hypoglycemia","volume":"54","author":"Mastaitis","year":"2005","journal-title":"Diabetes"},{"key":"2022031210074200000_B8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00125-002-0969-4","article-title":"Prediction of severe hypoglycaemia by angiotensin-converting enzyme activity and genotype in type 1 diabetes","volume":"46","author":"Pedersen-Bjergaard","year":"2003","journal-title":"Diabetologia"},{"key":"2022031210074200000_B9","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0140-6736(00)04405-6","article-title":"Activity of angiotensin-converting enzyme and risk of severe hypoglycaemia in type 1 diabetes mellitus","volume":"357","author":"Pedersen-Bjergaard","year":"2001","journal-title":"Lancet"},{"key":"2022031210074200000_B10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0009-9236(01)51508-8","article-title":"Losartan attenuates symptomatic and hormonal responses to hypoglycemia in humans","volume":"70","author":"Deininger","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"2022031210074200000_B11","first-page":"E852","article-title":"Opiate blockade enhances hypoglycemic counterregulation in normal and insulin-dependent diabetic subjects","volume":"260","author":"Caprio","year":"1991","journal-title":"Am J Physiol"},{"key":"2022031210074200000_B12","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1210\/jc.2009-0882","article-title":"Hypoglycemia-associated autonomic failure is prevented by opioid receptor blockade","volume":"94","author":"Leu","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031210074200000_B13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/ajh\/5.6.361","article-title":"The influence of captopril on the epinephrine response to insulin-induced hypoglycemia in humans. The interaction between the renin-angiotensin system and the sympathetic nervous system","volume":"5","author":"Madsen","year":"1992","journal-title":"Am J Hypertens"},{"key":"2022031210074200000_B14","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1161\/01.HYP.31.1.384","article-title":"AT1 and AT2 receptor blockade and epinephrine release during insulin-induced hypoglycemia","volume":"31","author":"Worck","year":"1998","journal-title":"Hypertension"},{"key":"2022031210074200000_B15","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/sj.bjp.0705838","article-title":"AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR","volume":"142","author":"Li","year":"2004","journal-title":"Br J Pharmacol"},{"key":"2022031210074200000_B16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol Rev"},{"key":"2022031210074200000_B17","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.lfs.2005.04.012","article-title":"ANG II increases 2-deoxyglucose uptake in mouse embryonic stem cells","volume":"77","author":"Han","year":"2005","journal-title":"Life Sci"},{"key":"2022031210074200000_B18","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1172\/JCI31547","article-title":"Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease","volume":"117","author":"Wang","year":"2007","journal-title":"J Clin Invest"},{"key":"2022031210074200000_B19","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1152\/ajpendo.00526.2005","article-title":"Glucocorticoid-deficient corticotropin-releasing hormone knockout mice maintain glucose requirements but not autonomic responses during repeated hypoglycemia","volume":"291","author":"Jacobson","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031210074200000_B20","doi-asserted-by":"crossref","first-page":"E678","DOI":"10.1152\/ajpendo.00383.2005","article-title":"Counterregulatory deficits occur within 24 h of a single hypoglycemic episode in conscious, unrestrained, chronically cannulated mice","volume":"290","author":"Jacobson","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031210074200000_B21","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2337\/db07-1755","article-title":"Ventromedial hypothalamic glucokinase is an important mediator of the counterregulatory response to insulin-induced hypoglycemia","volume":"57","author":"Levin","year":"2008","journal-title":"Diabetes"},{"key":"2022031210074200000_B22","doi-asserted-by":"crossref","first-page":"799","DOI":"10.7326\/0003-4819-119-8-199310150-00005","article-title":"Effect of caffeine on the recognition of and responses to hypoglycemia in humans","volume":"119","author":"Kerr","year":"1993","journal-title":"Ann Intern Med"},{"key":"2022031210074200000_B23","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature07181","article-title":"UCP2 mediates ghrelin's action on NPY\/AgRP neurons by lowering free radicals","volume":"454","author":"Andrews","year":"2008","journal-title":"Nature"},{"key":"2022031210074200000_B24","first-page":"39","article-title":"Secrets of the lac operon. Glucose hysteresis as a mechanism in dietary restriction, aging and disease","volume":"35","author":"Mobbs","year":"2007","journal-title":"Interdiscip Top Gerontol"},{"key":"2022031210074200000_B25","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2337\/diabetes.52.7.1749","article-title":"Estrogen blunts neuroendocrine and metabolic responses to hypoglycemia","volume":"52","author":"Sandoval","year":"2003","journal-title":"Diabetes"},{"key":"2022031210074200000_B26","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/jnr.20369","article-title":"Modulation of hypoglycemia-induced increases in plasma epinephrine by estrogen in the female rat","volume":"79","author":"Adams","year":"2005","journal-title":"J Neurosci Res"},{"key":"2022031210074200000_B27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brainres.2009.05.017","article-title":"Estradiol impairs hypothalamic molecular responses to hypoglycemia","volume":"1280","author":"Cheng","year":"2009","journal-title":"Brain Res"},{"key":"2022031210074200000_B28","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2337\/db08-1664","article-title":"Recurrent antecedent hypoglycemia alters neuronal oxidative metabolism in vivo","volume":"58","author":"Jiang","year":"2009","journal-title":"Diabetes"},{"key":"2022031210074200000_B29","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1074\/jbc.M506519200","article-title":"The fasting-induced adipose factor\/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity","volume":"281","author":"Mandard","year":"2006","journal-title":"J Biol Chem"},{"key":"2022031210074200000_B30","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1172\/JCI26640","article-title":"Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats","volume":"116","author":"Pocai","year":"2006","journal-title":"J Clin Invest"},{"key":"2022031210074200000_B31","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1523\/JNEUROSCI.5110-06.2007","article-title":"Phosphatidylinositol 3-Akt-kinase-dependent phosphorylation of p21(Waf1\/Cip1) as a novel mechanism of neuroprotection by glucocorticoids","volume":"27","author":"Harms","year":"2007","journal-title":"J Neurosci"},{"key":"2022031210074200000_B32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0083-6729(08)00605-5","article-title":"CXCL14 and insulin action","volume":"80","author":"Hara","year":"2009","journal-title":"Vitam Horm"},{"key":"2022031210074200000_B33","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.2337\/db10-0014","article-title":"Influence of insulin in the ventromedial hypothalamus on pancreatic glucagon secretion in vivo","volume":"59","author":"Paranjape","year":"2010","journal-title":"Diabetes"},{"key":"2022031210074200000_B34","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10549-009-0339-8","article-title":"Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer","volume":"119","author":"Fu","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"2022031210074200000_B35","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1002\/pmic.200800609","article-title":"Proteomic analysis of beta-catenin activation in mouse liver by DIGE analysis identifies glucose metabolism as a new target of the Wnt pathway","volume":"9","author":"Chafey","year":"2009","journal-title":"Proteomics"},{"key":"2022031210074200000_B36","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00018-003-3216-3","article-title":"Peroxisome proliferator-activated receptor alpha target genes","volume":"61","author":"Mandard","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"2022031210074200000_B37","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1172\/JCI200420468","article-title":"PPARalpha governs glycerol metabolism","volume":"114","author":"Patsouris","year":"2004","journal-title":"J Clin Invest"},{"key":"2022031210074200000_B38","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1210\/en.2005-1536","article-title":"Peroxisome proliferator-activated receptor-alpha-null mice have increased white adipose tissue glucose utilization, GLUT4, and fat mass: role in liver and brain","volume":"147","author":"Knauf","year":"2006","journal-title":"Endocrinology"},{"key":"2022031210074200000_B39","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/cmdc.200700143","article-title":"Mu opioid receptor antagonists: recent developments","volume":"2","author":"Goodman","year":"2007","journal-title":"ChemMedChem"},{"key":"2022031210074200000_B40","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1210\/jcem-49-6-838","article-title":"Substantial rise of plasma beta-endorphin levels after insulin-induced hypoglycemia in human subjects","volume":"49","author":"Nakao","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031210074200000_B41","first-page":"1325","article-title":"Beta-endorphin inhibits hypoglycemia-induced gene expression of corticotropin-releasing factor in the rat hypothalamus","volume":"130","author":"Suda","year":"1992","journal-title":"Endocrinology"},{"key":"2022031210074200000_B42","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2337\/diab.45.8.1030","article-title":"Impact of recent antecedent hypoglycemia on hypoglycemic cognitive dysfunction in nondiabetic humans","volume":"45","author":"Hvidberg","year":"1996","journal-title":"Diabetes"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/60\/1\/39\/399745\/zdb00111000039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/60\/1\/39\/399745\/zdb00111000039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T07:51:49Z","timestamp":1740469909000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/60\/1\/39\/15376\/Naloxone-but-Not-Valsartan-Preserves-Responses-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,14]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,9,14]]},"published-print":{"date-parts":[[2011,1,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db10-0326","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,14]]}}}